Solventum Corp. (SOLV) intrinsic value & 10-year financials
Solventum Corp. (SOLV) has a Graham intrinsic value of $134.22 per share. At $85.81 on Oct 17, 2026, the stock trades 36% below that value. Over the last 5 fiscal years revenue grew 0.8% a year to $8.3B, with an average return on invested capital of 12.7%.
- Graham intrinsic value
- $134.22
- Share price (Oct 17, 2026)
- $85.81
- Price vs Graham value
- 36% below
- Market cap
- $15.0B
- Revenue (FY2025)
- $8.3B
- Revenue growth (5-yr CAGR)
- 0.8%
- ROIC (10-yr avg)
- 12.7%
- Free cash flow (FY2025)
- -$10.0M
SOLV 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $8.3B | $1.6B | $8.88 | -$10.0M | 26.2% | 20.2% |
| FY2024 | $8.3B | $479.0M | $2.76 | $805.0M | 12.6% | 7.5% |
| FY2023 | $8.2B | $1.3B | $7.79 | $1.6B | 20.6% | 11.8% |
| FY2022 | $8.1B | $1.3B | $7.78 | $1.4B | 20.8% | 11.3% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Solventum revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Solventum returns on capital have been average, hovering around 12.7% ROIC over the decade.
Solventum capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Solventum is modeled at 4.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $134.22 per share.